InvestorsHub Logo

DewDiligence

01/04/19 5:43 PM

#386 RE: DewDiligence #385

DewDiligence

08/29/19 10:45 AM

#489 RE: DewDiligence #385

ABBV formally dumps Rova-T program after another phase-3 failure:

https://finance.yahoo.com/news/abbvie-discontinues-rovalpituzumab-tesirine-rova-124500700.html